首页 > 市场调查报告书 > 製药

药物开发

市场调查报告书

商品编码

1458138

全球药物发现资讯学市场规模、份额、成长分析（按工作流程、模式和服务）- 2024 年产业预测

Global Drug Discovery Informatics Market Size, Share, Growth Analysis, By Workflow, By Mode, By Services - Industry Forecast 2024

出版日期: 2024年03月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球药物发现资讯学市场规模为29.6亿美元，从2023年的32.9亿美元成长到77.6亿美元，预测期间（2024-2031年）复合年增长率为11.30%，预计将成长至美元。

In Silico建模技术的使用越来越多，药物开发资料的增加，高效能运算和线上服务的日益复杂，以及对新药物网站的需求不断增长。由于这些因素，药物发现资讯学市场预计在未来几年将会成长。由于引入增强型药物发现资讯技术，预计该行业的竞争将加剧。例如，2021 年 1 月，Certara, Inc. 宣布推出其 Simcyp 基于生理的药物动力学 (PBPK) 模拟平台的第 20 版。这种新模型有助于评估和分析怀孕和哺乳期间的药物使用。

此外，我们也协助做出关键选择，以最大限度地提高您药物的安全性和有效性。公司越来越多地转向资讯技术来加速药物开发。例如，Curve Therapeutics Ltd.计划在2021年使用CDD Vault平台来管理其生物编码的Microcycle平台。该平台是学术机构、生物技术公司和製药行业常用的託管平台，透过安全、简单和即时的资料共用来促进协作发现。

此外，全球COVID-19药物发现进程进展更快，这正在推动市场扩张。例如，研究人员采用针对人类 ACE2 受体和病毒蛋白的 DrugBank 药物进行虚拟筛检，以提供快速治疗方法。这些研究使用电脑方法来筛检可用于寻找抗 COVID-19 药物的小分子。

同样，该公司正在创建一系列数位服务和解决方案，以支持 COVID-19 药物开发的各个阶段。例如，IBM Visual Molecular Explorer 平台检查了一些针对冠状病毒 (SARS-CoV-2) 的化学物质。 Explorers 促进了最佳药物设计的早期阶段，Explorer 是人工智慧生成工件的开放原始码共用。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Accelrys（Biovia）
SchrAﾂｶdinger
Genedata
OpenEye Scientific Software
Certara
Dotmatics
Collaborative Drug Discovery（CDD）
Optibrium
Chemical Computing Group（CCG）
IBM Watson Health
PerkinElmer
BioSolveIT
Entelos
Dassault SystAﾂｨmes Biovia
XtalPi Inc.
OpenText
Benchling
MedChemica Ltd.
ChemAxon
BioSymetrics Inc.

简介目录

Product Code: SQMIG35I2209

Global Drug Discovery Informatics Market size was valued at USD 2.96 Billion in 2022 and is poised to grow from USD 3.29 Billion in 2023 to USD 7.76 Billion, at a CAGR of 11.30 % during the forecast period (2024-2031).

In-silico modeling techniques are being used more often, drug development data is increasing, high-performance computing and online services are becoming more advanced, and there is a growing need for novel pharmaceutical moieties. These factors are expected to propel the drug discovery informatics market upward in the upcoming years. It is anticipated that industry competition would increase with the introduction of enhanced drug discovery information technology. For instance, in January 2021, Certara, Inc. launched version 20 of their Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulation platform. The new models facilitate the evaluation and analysis of pharmaceutical use during the course of pregnancy and lactation.

Moreover, it helps clients make important choices that maximize the safety and efficacy characteristics of drugs. Businesses are increasingly adopting informatics technology in an effort to shorten the time it takes to conduct drug development. For instance, Curve Therapeutics Ltd. will use the CDD Vault platform in 2021 to manage its biologically encoded Microcycle platform. It is a popular hosted platform used by academic institutions, biotechnology companies, and the pharmaceutical industry for safe, easy, real-time data sharing that fosters cooperative discoveries.

Additionally, the global Covid-19 drug discovery process is moving more quickly, which is fueling market expansion. For instance, researchers employed virtual screening using medications from the DrugBank to target human ACE2 receptors and viral proteins in order to deliver prompt remedies. These studies used silico approaches to screen for tiny molecules that could be useful in the search for anti-Covid-19 drugs.

In a same vein, businesses are creating an array of digital services and solutions to support the many phases of Covid-19 drug development. The IBM Visual Molecular Explorer platform, for instance, looked into a portion of the chemicals made that were directed against the coronavirus (SARS-CoV-2). The early phases of optimal drug design were facilitated by the explorer's open-source sharing of AI-generated artifacts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segmental Analysis

The global drug discovery informatics market is segmented based on workflow, mode, services, application, end-use, and region. In terms of workflow, the market is segmented into discovery informatics, and development informatics. On the basis of categorization by mode, the market is segmented into outsourced, and in-house. Based on services, the market is segmented into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and other services. Based on region the global drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Drug Discovery Informatics Market

The demand for innovative pharmaceuticals has increased as a result of the rising prevalence of various diseases and the necessity for efficient treatment options. By facilitating effective data analysis, predictive modeling, and virtual screening, drug discovery informatics significantly contributes to the acceleration of the drug development process and consequently drives market growth.

Restraints in the Global Drug Discovery Informatics Market

Software licensing, hardware infrastructure, and trained staff are only a few of the significant upfront expenditures associated with implementing drug discovery informatics systems and technologies. Market expansion may be hindered by these high implementation costs, which may be an impediment for smaller businesses or organizations with tighter budgets.

Market Trends of the Global Drug Discovery Informatics Market

Growing Adoption of Machine Learning and Artificial Intelligence (AI and ML): In order to improve accuracy and efficiency, drug discovery informatics is incorporating AI and ML technologies more and more. Advanced data analysis, predictive modeling, and virtual screening are made possible by these technologies, which speed up the drug discovery process and increase success rates.

Growing Need for Cloud-Based Informatics Solutions: The drug discovery informatics industry has seen a notable increase in the use of cloud computing. With the scalability, flexibility, and affordability of cloud-based informatics solutions, businesses can effectively handle, store, and analyze massive amounts of data. They also make it easier for research teams to share data and collaborate remotely, which increases acceptance.

Emphasis on Targeted Therapies and customized Medicine: The market for drug discovery informatics has been impacted by the move toward targeted therapies and customized medicine. In order to find particular biomarkers, analyze patient data, and create customized treatments, informatics solutions are essential. Informatics tools for tailored drug discovery are being developed in response to the increasing focus on precision medicine.

Integration of Big Data Analytics: Big data analytics has been integrated into drug discovery informatics as a result of the availability of extensive genomic, proteomic, and clinical data. Researchers can uncover new therapeutic targets, get insightful knowledge, and streamline the drug development process by utilizing advanced analytics approaches including data mining, pattern recognition, and predictive modeling.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Drug Discovery Informatics Market by Workflow

Market Overview
Discovery Informatics and Development Informatics

Global Drug Discovery Informatics Market by Mode

Market Overview
Outsourced
and In-house

Global Drug Discovery Informatics Market by Services

Market Overview
Sequence Analysis Platforms
Molecular Modeling
Docking
Clinical Trial Data Management
and Other Services

Global Drug Discovery Informatics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Accelrys (Biovia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SchrA¶dinger
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genedata
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpenEye Scientific Software
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Certara
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dotmatics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collaborative Drug Discovery (CDD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optibrium
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chemical Computing Group (CCG)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBM Watson Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioSolveIT
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Entelos
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dassault SystA¨mes Biovia
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
XtalPi Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpenText
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Benchling
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedChemica Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemAxon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioSymetrics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments